D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3376
Bank of Marin Bancorp
BMRC
$427M
| $966K | ﹤0.01% |
+37,672
| New | +$977K |
2026 Q1
0 quarters
|
|
3377
CALL
Coca-Cola Consolidated
COKE
$13.6B
| $959K | ﹤0.01% |
+5,000
| New | +$876K |
2026 Q1
0 quarters
|
|
3378
PUT
UBS Group
UBS
$146B
| $957K | ﹤0.01% |
+24,500
| New | +$1.05M |
2026 Q1
0 quarters
|
|
3379
Scorpio Tankers
STNG
$4.15B
| $957K | ﹤0.01% |
+12,813
| New | +$859K |
2026 Q1
0 quarters
|
|
3380
DHT Holdings
DHT
$3.78B
| $954K | ﹤0.01% |
+52,220
| New | +$832K |
2026 Q1
0 quarters
|
|
3381
PUT
Curtiss-Wright
CW
$18.5B
| $954K | ﹤0.01% |
1,400
-1,900
| -58% | -$1.26M |
2025 Q3
2 quarters
|
|
3382
PUT
Eagle Materials
EXP
$5.23B
| $947K | ﹤0.01% |
+5,000
| New | +$1.06M |
2026 Q1
0 quarters
|
|
3383
PUT
United Rentals
URI
$65.2B
| $947K | ﹤0.01% |
1,300
-27,400
| -95% | -$23M |
2013 Q2
51 quarters
|
|
3384
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$511M
| $946K | ﹤0.01% |
20,358
-1,500
| -7% | -$73.1K |
2024 Q1
8 quarters
|
|
3385
PUT
Jack in the Box
JACK
$243M
| $946K | ﹤0.01% |
97,800
-84,600
| -46% | -$1.5M |
2025 Q3
2 quarters
|
|
3386
Filana Therapeutics
FLNA
$36.8M
| $945K | ﹤0.01% |
559,205
+89,879
| +19% | +$185K |
2025 Q4
1 quarter
|
|
3387
The Joint Corp
JYNT
$97.7M
| $945K | ﹤0.01% |
106,759
+3,869
| +4% | +$35.2K |
2022 Q2
15 quarters
|
|
3388
PUT
Camping World
CWH
$292M
| $944K | ﹤0.01% |
138,200
+31,800
| +30% | +$328K |
2025 Q1
4 quarters
|
|
3389
Lamar Advertising Co
LAMR
$15B
| $941K | ﹤0.01% |
7,430
-35,648
| -83% | -$4.67M |
2024 Q4
5 quarters
|
|
3390
Inseego
INSG
$73M
| $935K | ﹤0.01% |
84,115
+60,589
| +258% | +$682K |
2025 Q4
1 quarter
|
|
3391
PUT
Rio Tinto
RIO
$147B
| $933K | ﹤0.01% |
10,000
| – | – |
2022 Q3
14 quarters
|
|
3392
Business First Bancshares
BFST
$1.01B
| $931K | ﹤0.01% |
34,434
+16,899
| +96% | +$464K |
2025 Q3
2 quarters
|
|
3393
CALL
AB InBev
BUD
$160B
| $930K | ﹤0.01% |
13,400
-30,300
| -69% | -$2.19M |
2025 Q2
3 quarters
|
|
3394
Commercial Vehicle Group
CVGI
$114M
| $928K | ﹤0.01% |
272,165
-328,527
| -55% | -$677K |
2014 Q2
47 quarters
|
|
3395
Krispy Kreme
DNUT
$538M
| $924K | ﹤0.01% |
272,603
-547,970
| -67% | -$1.89M |
2024 Q3
6 quarters
|
|
3396
Solid Biosciences
SLDB
$615M
| $924K | ﹤0.01% |
128,348
+88
| +0.1% | +$565 |
2025 Q4
1 quarter
|
|
3397
Shore Bancshares
SHBI
$752M
| $921K | ﹤0.01% |
+49,293
| New | +$917K |
2026 Q1
0 quarters
|
|
3398
Core Scientific
CORZ
$4.65B
| $918K | ﹤0.01% |
61,333
-167,211
| -73% | -$2.85M |
2024 Q4
5 quarters
|
|
3399
CALL
Cummins
CMI
$73.3B
| $915K | ﹤0.01% |
1,700
-2,300
| -58% | -$1.3M |
2025 Q1
4 quarters
|
|
3400
CALL
Embraer S.A. ADS
EMBJ
$12.8B
| $914K | ﹤0.01% |
15,400
-7,200
| -32% | -$493K |
2025 Q4
1 quarter
|
|
Similar funds
D.E. Shaw & Co's Q1 2026 Portfolio in Review
As of Q1 2026, D.E. Shaw & Co held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in Venture Global Inc worth $211M.
- D.E. Shaw & Co's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- D.E. Shaw & Co added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- D.E. Shaw & Co opened 685 new positions and closed 756 in Q1 2026.
- D.E. Shaw & Co's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.